Banerjee Rahul, Loren Alison W
Division of Hematology/Oncology Department of Medicine University of California San Francisco San Francisco California USA.
Division of Hematology/Oncology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
EJHaem. 2021 Mar 4;2(2):272-275. doi: 10.1002/jha2.179. eCollection 2021 May.
In a recent multicenter analysis, long geographic distances predicted loss to follow-up (LTF) among allogeneic hematopoietic cell transplantation (HCT) survivors. We hypothesized that lower frequencies of patient interactions (including in-person appointments and telemedicine encounters) would predict LTF rather than long driving distances. However, in our retrospective single-center analysis of 263 HCT survivors, the only predictors of LTF were residence in the furthest driving-distance quartile and Medicaid insurance (but not annualized frequencies of patient interactions). Our findings suggest that telemedicine may not necessarily "rescue" long-distance HCT survivors from LTF. Other solutions, for example patient-specific partnerships with local providers, may be helpful.
在最近的一项多中心分析中，地理距离较远预示着异基因造血细胞移植（HCT）幸存者会失访（LTF）。我们推测，患者互动频率较低（包括面对面预约和远程医疗会诊）会预示失访，而非驾车距离远。然而，在我们对263名HCT幸存者进行的回顾性单中心分析中，失访的唯一预测因素是居住在驾车距离最远的四分位数区域以及参加医疗补助保险（而非患者互动的年化频率）。我们的研究结果表明，远程医疗不一定能使居住在远方的HCT幸存者免于失访。其他解决方案，例如与当地医疗机构建立针对患者的合作关系，可能会有所帮助。
